monoclonal antibody

You have access
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Ming Bai, Meng Wang, Ting Deng, Yuxian Bai, Kai Zang, Zhanhui Miao, Wenlin Gai, Liangzhi Xie and Yi Ba

Cancer Biology & Medicine March 2022, 19 (3) 358-369; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0388
You have access
Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
Brandon M. Bordeau and Joseph P. Balthasar

Cancer Biology & Medicine August 2021, 18 (3) 649-664; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0704
You have access
Current applications and future prospects of nanotechnology in cancer immunotherapy
Sen Yan, Peng Zhao, Tingting Yu and Ning Gu

Cancer Biology & Medicine August 2019, 16 (3) 486-497; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0493
You have access
Monoclonal Antibodies in Cancer Therapy
Yu-Ting GUO, Qin-Yu HOU and Nan WANG

Clinical Oncology and Cancer Research December 2011, 8 (4) 215-219; DOI: https://doi.org/10.1007/s11805-011-0583-7
You have access
Studies on the Distribution and Radioimmunoimaging of ^99mTc-Labeled 5-Fluorouracil Loaded Immunological Nanoparticles in Tissues and Human Gastric Carcinoma Xenografts
Kaihong Huang, Jianhua Liu, Zhaohua Zhu, Xuexian Li and Xianping Lu

Chinese Journal of Clinical Oncology October 2007, 4 (5) 307-312; DOI: https://doi.org/10.1007/s11805-007-0307-1

Main menu